This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Japan report on hepatitis B core promoter mutations, which are significantly associated with hepatocellular carcinoma in certain hepatitis B-infected patients. The team compared the full genome sequences of the hepatitis B virus from the blood of 37 patients with liver cancer and 38 patients without cancer. They also analyzed part of the core promoter region sequences from another 40 liver cancer patients and a second group of non-cancer patients.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.